100
Participants
Start Date
July 31, 2001
Primary Completion Date
September 30, 2012
Study Completion Date
March 31, 2013
E75 + GM-CSF vaccine
Dose escalation scheme involving three patients each receiving injection of 100, 500, or 1,000 mcg E75 + GM-CSF monthly for 6 months. HLA-A2 and HLA-A3 status determined. HLA-A2+ and HLA-A3+ patients receive the vaccine; HLA-A2- and HLA-A3- enrolled to the control arm.
Windber Medical Center, Windber
Walter Reed National Military Medical Center, Bethesda
Uniformed Services University of the Health Sciences
FED
COL George Peoples, MD, FACS
FED